Details for Patent: 8,361,500
✉ Email this page to a colleague
Which drugs does patent 8,361,500 protect, and when does it expire?
Patent 8,361,500 protects VARUBI and is included in one NDA.
This patent has sixteen patent family members in ten countries.
Summary for Patent: 8,361,500
| Title: | Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| Abstract: | Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms. |
| Inventor(s): | Zhihui Qiu, Wing-Kee Philip Cho, Na Zhao, Victor Ming-She Wong |
| Assignee: | Opko Health Inc |
| Application Number: | US12/531,966 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Process; Dosage form; |
Drugs Protected by US Patent 8,361,500
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | VARUBI | rolapitant hydrochloride | TABLET;ORAL | 206500-001 | Sep 1, 2015 | RX | Yes | Yes | 8,361,500 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,361,500
| PCT Information | |||
| PCT Filed | March 20, 2008 | PCT Application Number: | PCT/US2008/003653 |
| PCT Publication Date: | October 02, 2008 | PCT Publication Number: | WO2008/118331 |
International Family Members for US Patent 8,361,500
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 065802 | ⤷ Start Trial | |||
| Canada | 2681465 | ⤷ Start Trial | |||
| Chile | 2008000819 | ⤷ Start Trial | |||
| European Patent Office | 2136793 | ⤷ Start Trial | |||
| Spain | 2406934 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
